- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01262833
Pudendal Assessment in Erectile Dysfunction (INDEED)
March 13, 2014 updated by: University of Pennsylvania
A Cohort Study of the Functional Significance of Internal Pudendal Artery Stenoses in Patients With Erectile Dysfunction
The study will address the role of internal pudendal artery disease in erectile dysfunction (ED), and whether it might eventually be amenable to intervention with stenting.
There is currently a small trial investigating the potential benefit of stenting for erectile dysfunction, but the relationship between pelvic arterial stenoses and erectile dysfunction is not yet proven.
The investigators intend to perform angiography on patients both with and without erectile dysfunction, to see whether internal pudendal artery disease is more common in the population with erectile dysfunction.
In addition to angiography, stenoses will be examined using fractional flow reserve.
The degree of internal pudendal artery disease will then be correlated with the degree of erectile dysfunction using a validated questionnaire, the International Index of Erectile Function (IIEF).
Patients will then complete IIEF questionnaires for 5 years to assess the relationship between internal pudendal artery disease and progression of erectile dysfunction.
Study Overview
Status
Terminated
Conditions
Study Type
Observational
Enrollment (Actual)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
sexually active men, scheduled for cardiac catheterization or peripheral artery catheterization, who have at least one risk factor for ED
Description
Inclusion Criteria:
- As above, men with one risk factor for ED such as age>55, diabetes, hyperlipidemia, smoking, hypertension, coronary disease or peripheral arterial disease
Exclusion Criteria:
- Patients with ED from a non-arterial cause, including hormonal, neurological, or trauma-related (as determined by past medical history routinely performed prior to catheterization)
- Patients requiring urgent catheterization (e.g. acute coronary syndrome or cardiogenic shock)
- Patients with a creatinine >1.5 mg/dL and those deemed at increased renal risk (such as from receiving >200 mL of dye during the primary procedure, post renal transplant or single kidney), as the additional contrast dye required for angiography would pose an undue risk of progressive kidney disease
- Patients with other illnesses that reduce their life expectancy to less than one year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Cases
Patients with erectile dysfunction by ILEF questionnaire
|
|
Controls
Patients without erectile dysfunction by ILEF questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pudendal Assessment in Erectile Dysfunction
Time Frame: Up to Five years
|
The primary exposure will be hemodynamically significant internal pudendal artery stenoses as a predictor of erectile dysfunction
|
Up to Five years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pudendal Assessment in Erectile Dysfunction
Time Frame: up to five years
|
Secondary analyses will include correlation between bilateral disease and erectile dysfunction, as well as the contribution of small vessel disease (distal to the internal pudendal artery).
The severity of disease by IIEF questionnaire will also be compared to the severity of disease by angiography.
We will continue through 5-year follow-up of patients with yearly IIEF questionnaires to determine if changes in erectile dysfunction can be predicted by baseline internal pudendal artery disease.
|
up to five years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Howard Herrmann, M.D., University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
November 12, 2010
First Submitted That Met QC Criteria
December 16, 2010
First Posted (Estimate)
December 17, 2010
Study Record Updates
Last Update Posted (Estimate)
March 14, 2014
Last Update Submitted That Met QC Criteria
March 13, 2014
Last Verified
January 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 811936
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erectile Dysfunction
-
Taksim Egitim ve Arastirma HastanesiActive, not recruitingErectile Dysfunction Vascular Erectile Dysfunction Atherogenic DyslipidemiaTurkey (Türkiye)
-
Labbafinejad Medical CenterNot yet recruitingErectile Dysfunction | Erectile Dysfunction Due to General Medical Condition | Erectile Dysfunction Due to Arterial Insufficiency | Erectile Dysfunction Associated With Type 2 Diabetes Mellitus | Erectile Dysfunction Due to Arterial Disease | Erectile Dysfunction Due to NeuropathyIran
-
Ryan Flannigan, MDRecruitingErectile Dysfunctions | Erectile Function | Erectile Dysfunction (ED)Canada
-
Cairo UniversityRecruitingErectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Simple Prostatectomy | Erectile Dysfunction With Diabetes Mellitus | Erectile Dysfunction Due to Arterial Disease | Erectile Dysfunction Due to Injury | Erectile Dysfunction Due to Neuropathy and other conditionsEgypt
-
Mansoura University HospitalNot yet recruitingErectile Dysfunction Due to Venous Disorder | Erectile Dysfunction (ED)
-
University of VirginiaActive, not recruitingErectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Radiation Therapy | Erectile Dysfunction Due to General Medical Condition | Erectile Dysfunction Due to Arterial InsufficiencyUnited States
-
University of BaghdadCompletedSexual Dysfunction | Erectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Radiation Therapy | Sexual Abstinence | Erectile Dysfunction With Diabetes Mellitus | Sexual Desire Disorder | Erectile Dysfunction Following Cryotherapy | Erectile Dysfunction... and other conditionsIraq
-
University College, LondonRecruitingRadical Prostatectomy | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Due to Arterial Insufficiency | Robotic Radical ProstatectomyUnited Kingdom
-
Assiut UniversityNot yet recruiting
-
Rigicon, Inc.RecruitingErectile Dysfunction (ED)United States